China National Accord Medicines (SZSE:000028) Change In Receivables

: ¥0 Mil (TTM As of Mar. 2023)

View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's change in receivables for the quarter that ended in Mar. 2023 was ¥0 Mil. It means China National Accord Medicines's Accounts Receivable stayed the same from Dec. 2022 to Mar. 2023 .

China National Accord Medicines's change in receivables for the fiscal year that ended in Dec. 2022 was ¥1,227 Mil. It means China National Accord Medicines's Accounts Receivable declined by ¥1,227 Mil from Dec. 2021 to Dec. 2022 .

China National Accord Medicines's Accounts Receivable for the quarter that ended in Mar. 2023 was ¥19,303 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. China National Accord Medicines's Days Sales Outstanding for the three months ended in Mar. 2023 was 94.26.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. China National Accord Medicines's liquidation value for the three months ended in Mar. 2023 was ¥-3,257 Mil.

China National Accord Medicines Change In Receivables Historical Data

The historical data trend for China National Accord Medicines's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Change In Receivables

-1,663.98

-793.31

-2,989.96

-2,120.78

1,227.01

China National Accord Medicines Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Change In Receivables																-	-	-	-	-

China National Accord Medicines Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

China National Accord Medicines (SZSE:000028) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

China National Accord Medicines's Days Sales Outstanding for the quarter that ended in Mar. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	19303.106	/	18686.818	*	91
=	94.26

2. In Ben Graham's calculation of liquidation value, China National Accord Medicines's accounts receivable are only considered to be worth 75% of book value:

China National Accord Medicines's liquidation value for the quarter that ended in Mar. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	5946.206	-	27998.28	+	0.75 * 19303.106	+	0.5 * 8635.347
=	-3,257

China National Accord Medicines Change In Receivables Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Change In Receivables

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines